Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Disc Medicine, Inc. - Common Stock
(NQ:
IRON
)
47.75
+0.28 (+0.59%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
484,918
Open
47.39
Bid (Size)
47.75 (2)
Ask (Size)
52.14 (1)
Prev. Close
47.47
Today's Range
47.39 - 48.74
52wk Range
25.60 - 77.60
Shares Outstanding
5,000,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Disc Medicine Announces Presentation of New Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2024 American Society of Nephrology (ASN) Kidney Week
Today 8:00 EDT
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Steve Caffé, MD as Chief Regulatory Officer
September 19, 2024
Dr. Steve Caffé is an accomplished industry executive with over 25 years of expertise in global product development and regulatory affairs
From
Disc Medicine Inc
Via
GlobeNewswire
Performance
YTD
-20.06%
-20.06%
1 Month
-3.61%
-3.61%
3 Month
+1.79%
+1.79%
6 Month
+49.03%
+49.03%
1 Year
-0.21%
-0.21%
More News
Read More
Disc Medicine to Participate in Upcoming Investor Conferences
August 30, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
IRON Stock Earnings: Disc Medicine Beats EPS for Q2 2024
August 08, 2024
Via
InvestorPlace
Disc Medicine Reports Second Quarter 2024 Financial Results and Provides Business Update
August 08, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
S&P 500 Edges Lower; RH Shares Plunge After Q1 Results
June 14, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
June 14, 2024
Via
Benzinga
Gold Gains 1%; US Consumer Sentiment Falls In June
June 14, 2024
Via
Benzinga
Hasbro, Tutor Perini, Arm Holdings And Other Big Stocks Moving Higher On Friday
June 14, 2024
Via
Benzinga
Disc Medicine Announces Underwritten Offering of Common Stock
June 14, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 Congress
June 14, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine to Participate in the Jefferies Global Healthcare Conference
May 30, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress
May 14, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference
May 13, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
IRON Stock Earnings: Disc Medicine Misses EPS for Q1 2024
May 09, 2024
Via
InvestorPlace
Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update
May 09, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Top 3 Health Care Stocks You'll Regret Missing This Month
April 02, 2024
Via
Benzinga
Gold Gains 1%; CXApp Shares Spike Higher
April 01, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 01, 2024
Via
Benzinga
Crude Oil Moves Higher; Oxford Industries Shares Fall After Q4 Results
April 01, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
April 01, 2024
Via
Benzinga
Disc Medicine Stock Plunges As Light Sensitivity Treatment Data Confounded Due To Outsized Placebo Response
April 01, 2024
Via
Benzinga
Disc Medicine Plummets 59% After Placebo Effect Confounds Sunlight Sensitivity Study
April 01, 2024
Via
Investor's Business Daily
Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)
April 01, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.